Human carbonic anhydrase modulators: the past, present, and future
Simone Giovannuzzi1, Claudiu T Supuran1
1NEUROFARBA Department, Section of Pharmaceutical Science, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Trends in Pharmacological Sciences
|August 7, 2025
Summary
Human carbonic anhydrases (hCAs) are enzymes with therapeutic potential beyond glaucoma. Research is expanding their use for obesity, inflammation, tumors, and neurodegeneration.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Human carbonic anhydrases (hCAs) are metalloenzymes historically linked to ocular and renal conditions.
- Current antiglaucoma and diuretic drugs target hCAs, but their therapeutic scope is broader.
Purpose of the Study:
- To review the evolving understanding of hCA modulators.
- To highlight hCA dysregulation in diverse pathologies.
- To discuss therapeutic development progress.
Main Methods:
- Literature review of hCA research.
- Analysis of hCA roles in various diseases.
- Examination of therapeutic strategies targeting hCAs.
Main Results:
- hCA modulators show potential in obesity, inflammation, hypoxic tumors, neurodegeneration, and neuropathic pain.
- Dysregulation of CAs is implicated in numerous diseases.
- Significant progress has been made in developing hCA modulators for therapeutic applications.
Conclusions:
- hCA modulators represent a promising therapeutic avenue for a wide range of diseases.
- Further research into hCA modulation is warranted for novel treatment strategies.
Related Concept Videos
Bicarbonate-Carbonic Acid Buffer
3.0K
The carbonic acid-bicarbonate buffer system is critical for maintaining the body's pH balance. It operates on the equilibrium:
3.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
Renal Regulation of Acid-Base Balance
704
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
704
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Respiratory Regulation of Acid-Base Balance
666
Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2 and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
666
Cholinergic Antagonists: Pharmacokinetics
561
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
561


